About the project


V.A. Cure is a European MSCA-ITN network aiming to uncover core mechanisms of initiation and maintenance of Vascular Anomalies (VAs) and to leverage this information for establishing novel therapeutic strategies. The network consortium consists of 7 academic laboratories and 2 companies from across Europe, and is supported by 9 partner organisations.
The 14 Early Stage Researchers (ESRs) will be a part of  the unique international PhD program, consisting of an individual research project, the network’s training programme, intersectoral secondments and outreach activities. Project goal is to  ensure a comprehensive perception of the research and drug/technology development in pharma industry/biotech and academia.

One of our Beneficiaries Finnadvance company will present organ-on-chip in Munich! Join to hear about this amazing invention!
#VACure #MSCA #EUproject #Horizon2020 https://t.co/QhITrMR5F1

VACure1 photo

Meet us at @WearableTech conference in Munich today and tomorrow!
Prateek will be presenting our Organ-on-chips and related technologies for off-body research and applications
#WTEU20 https://t.co/anRBBsrOeu

Project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 814316